Chloride → HCID 131723179, compound
Reaction equation
[C:1]([C:4]1[C:5]([C:23](=[O:25])[CH3:24])=[C:6]([OH:22])[C:7](=[CH:20][CH:21]=1)[C:8]([O:10][CH2:11][CH2:12]OCCOCCO)=[O:9])(=[O:3])[CH3:2].[Cl-].C(OC1C(=CC=CC=1)C(O)=O)(=O)C.C(O)C[CH2:42][CH2:43][CH2:44][CH2:45][CH2:46][CH2:47][CH2:48][CH2:49][OH:50].C(OC(C)C)(C)C>>[C:1]([C:4]1[C:5]([C:23](=[O:25])[CH3:24])=[C:6]([OH:22])[C:7](=[CH:20][CH:21]=1)[C:8]([O:10][CH2:11][CH2:12][CH2:42][CH2:43][CH2:44][CH2:45][CH2:46][CH2:47][CH2:48][CH2:49][OH:50])=[O:9])(=[O:3])[CH3:2]Participants
6
Procedure
The compound (IV) was prepared according to the procedure described in Example 1 for the synthesis of (XIX), starting from 5 g of the chloride of acetylsalicylic acid, 3.5 ml of TEA and 2.17 g of 1.10-decandiol. The product was purified by chromatography utilizing an eluent mix constituted by ethylether/hexane 7:3 (v/v). The intermediate fractions were collected, the solvent was evaporated under reduced pressure and a solid residue was obtained which, trirurated with isopropyl ether, produced 1.37 g of 1.10-decandiol bis-acetylsalicylate (IV) with m.p.=75° C.
Workup
- customThe compound (IV) was prepared
- customThe product was purified by chromatography
- additionmix
- customThe intermediate fractions were collected
- customthe solvent was evaporated under reduced pressure
- customa solid residue was obtained which
Sources & evidence
- ORD record
- ord-b0d5989124334152b46aa14de0f2b988
- Source dataset
- uspto-grants-2002_04
- Patent number
- US06369260B1
Reaction notes
Loading…